جست‌وجوی استاد و پژوهشگر

Katherine Rushمشاهده پروفایل

استادیار

• Biochemistry
• Metalloenzymology
• Bioinorganic Chemistry
• +۵ مورد دیگر

Katherine Rush is an Assistant Professor in the Department of Chemistry and Biochemistry at Auburn University. Her research focuses on metalloenzyme catalysis, bioinorganic chemistry, and X-ray spectroscopic techniques. She has held academic positions including Visiting Assistant Professor at Reed College (2020–2022) and Postdoctoral Fellow at Oregon Health and Science University (2018–2023). She earned a Ph.D. in Chemical Biology from the University of Michigan (2013–2018) and a B.S. in Chemistry from the University of Tennessee (2010–2013). Research Interests: Rush’s laboratory investigates the molecular mechanisms of metalloenzymes involved in thyroid hormone regulation, oxygen activation, and antimicrobial natural product biosynthesis. A key focus is selenium-containing amino acids as tools for element-specific spectroscopic characterization. Techniques employed include X-ray absorption spectroscopy (XAS), biochemical assays (SDS-PAGE, Western blotting), and analytical methods (ICP-OES, LC-MS). Teaching: She instructs BCHE 7270 – Biochemical Research Techniques, emphasizing hands-on experience with advanced biochemical methodologies. Grants & Advising: While specific grants are not listed, her research reflects significant interdisciplinary collaboration in environmental and biomedical chemistry. No current advisees are explicitly noted. Labs/Teams: The Rush Lab at Auburn University specializes in integrating spectroscopic and biochemical approaches to study metalloenzymes, particularly targeting systems relevant to human health such as copper-dependent monooxygenases and selenium-labeled proteins.

Renu Kowluruمشاهده پروفایل

استاد

• Diabetic Retinopathy
• Mitochondrial Dysfunction
• Epigenetics
• +۳ مورد دیگر

Renu Kowluru is a Professor and Director of Translational Research at the Department of Ophthalmology and Visual & Anatomical Sciences , Wayne State University. Her research focuses on the role of mitochondrial dysfunction and epigenetic modifications in the pathogenesis of diabetic retinopathy , including the phenomenon of metabolic memory where retinal damage persists even after glycemic control. Dr. Kowluru’s work has been recognized by her induction into Wayne State University’s Academy of Scholars (2011), designation as a World Expert by Expertscape (2021), and inclusion in Research.com’s list of the World’s Best Scientists (2025). She has served on high-impact committees such as the National Eye Institute’s Strategic Planning Committee (2020) and the National Eye Advisory Council (2020–2024). Her research has identified mitochondrial DNA damage as a critical driver of oxidative stress in diabetic retinopathy and pioneered the study of mitochondrial epigenetics in this context. She has secured continuous NIH funding (R01 EY014370, EY017313, EY022230, EY033516). The trends in her recent publications highlight long noncoding RNAs , ferroptosis , and mitochondrial DNA repair as central themes. Scientific Awards Wayne State University Academy of Scholars (2011) Expertscape World Expert in Diabetes Complications (2021) Research.com World’s Best Scientists (2025) Dr. Kowluru’s grants and committee roles reflect her leadership in advancing diabetic retinopathy research , including contributions to the Foundation for Vision Research and the Mary Tyler Moore Vision Collaborative Community. Her collaborations span institutions like the Juvenile Diabetes Research Foundation and the American Diabetes Association.

Warren D. Krugerمشاهده پروفایل

استاد

• Amino Acid Genetics
• Cancer Metabolism
• Mouse Models
• +۵ مورد دیگر

Warren D. Kruger is a Professor in the Cancer Signaling and Microenvironment program at Fox Chase Cancer Center, part of Temple University Health System. His research focuses on amino acid genetics and human disease, particularly methionine metabolism and its role in cancer and metabolic disorders. He leads an active laboratory studying the methionine salvage pathway gene MTAP and cystathionine beta-synthase (CBS) deficiency using mouse models. Educational Background: BA in Biology, Cornell University, Ithaca, NY (1985) PhD in Genetics, University of California at San Francisco, San Francisco, CA (1991) Dr. Kruger's research centers on understanding how mutations affecting key enzymes in methionine metabolism cause disease. His lab investigates four major projects: the role of MTAP in tumorigenesis, targeting MTAP-loss for cancer therapy, mouse models for CBS deficiency, and alterations in serum amino acids in renal cell carcinoma. His work has significant implications for understanding metabolic pathways connecting folate/nucleotide biosynthesis, sulfur and redox metabolism, choline and lipid metabolism, and methylation reactions involving S-adenosylmethionine. Analysis of Dr. Kruger's recent publications reveals a strong focus on CBS deficiency and MTAP deletion in cancer. His research employs mouse models, metabolic profiling, and therapeutic development approaches. Key trends include developing gene therapy for metabolic disorders, identifying biomarkers for renal cell carcinoma, and exploring novel cancer therapies targeting metabolic vulnerabilities. Scientific Awards: American Heart Association Researcher Award (2006) Elected President of Fox Chase Cancer Center Faculty Senate (2010) Dr. Kruger leads an active research laboratory with several senior staff members including Sapna Gupta, PhD (Senior Research Associate), Baiqing Tang, PhD (Senior Research Associate), Hyung-Ok Lee, PhD (Assistant Research Professor), and Liqun Wang, MD (Senior Technical Specialist). His lab has received significant funding for research on methionine metabolism, CBS deficiency, and MTAP deletion in cancer. Current projects include developing novel therapeutic approaches for homocystinuria and exploring metabolic vulnerabilities in cancer cells. The Kruger lab maintains four major research areas focused on methionine metabolism: understanding the role of MTAP in tumorigenesis, developing the MTA protection strategy for cancer therapy, creating mouse models for CBS deficiency, and investigating serum amino acid alterations as biomarkers for renal cell carcinoma. The lab employs advanced techniques including metabolic profiling, gene therapy approaches, and sophisticated molecular analyses to address these research questions.

SIRMA GEYİKمشاهده پروفایل

استاد

• Neurology
• Headache/Migraine Research
• Multiple Sclerosis
• +۵ مورد دیگر

Professor SIRMA GEYİK is a distinguished faculty member at Gaziantep University Faculty of Medicine, Department of Internal Medicine and Department of Neurology. She has been serving as a Professor since 2023, following her progression from Associate Professor (2018) and Assistant Professor (2013) at the same institution. Dr. Geyik completed her medical education at Dokuz Eylul University Faculty of Medicine (1995-2001) and specialized in Neurology at Gaziantep University (2002-2006). Her educational background includes: Medical Specialization in Neurology (2002-2006) at Gaziantep University Faculty of Medicine, Department of Internal Medicine, Department of Neurology Medical Degree (1995-2001) from Dokuz Eylul University Faculty of Medicine Dr. Geyik's research primarily focuses on neurology with special emphasis on headache disorders, particularly migraine pathophysiology and treatment. Her work spans multiple areas including neurogenetics, oxidative stress mechanisms in neurological disorders, neuroimaging, and clinical neurology. She has conducted extensive research on the genetic and molecular aspects of migraine, including studies on CHRNA7 gene variations, WNT signaling pathway, and oxidative DNA damage. Her scholarly contributions also extend to multiple sclerosis, stroke, peripheral neuropathies, and neurosurgical conditions. Her recent publications reveal a strong trend toward molecular and genetic mechanisms underlying headache disorders, with particular interest in how gene expression, methylation status, and copy number variations contribute to migraine pathogenesis. She has also maintained significant clinical research in neurosurgical conditions, multiple sclerosis, and peripheral nerve disorders. Her scientific achievements include: 2016 Study Award for "Migren Hastalığının Patofizyolojisinde Apelin ve Apelin Reseptörünün Olası Rolü" at XVI. Clinical Biochemistry Congress 2013 Presentation Award at The 7th World Congress on Controversies in Neurology (CONy) Dr. Geyik has supervised multiple graduate students, including FERHAT KILIÇASLAN (thesis on tension-type headache methylation analysis), MEHMET FATİH ÖZALTUN (thesis on CHRNA7 gene variations in migraine), ERMAN ALTUNIŞIK (thesis on oxidative metabolism in migraine), and FİKRET BAKLA (thesis on digital subtraction angiography). She has been involved in several research projects, including studies on vitamin D and homocysteine levels in stroke patients, migraine pathophysiology related to urotensin, and oxidative stress in ischemic stroke. Dr. Geyik is actively involved in clinical work and teaching at Gaziantep University, where she has taught numerous courses on neurological sciences, headache disorders, cerebrovascular diseases, muscle diseases, epilepsy, and neurological examination techniques. She is a member of both the Headache and Pain Studies Association (since 2016) and the Turkish Neurological Association (since 2012).

Xiao-Feng Yangمشاهده پروفایل

استاد

• Cardiovascular Sciences
• Epigenetic Pathology
• Vascular Inflammation
• +۴ مورد دیگر

Xiao-Feng Yang, MD, PhD, FAHA is a Professor and Associate Director at the Lemole Center for Integrated Lymphatics and Vascular Research at Temple University's Lewis Katz School of Medicine. He holds multiple professorial appointments across departments including Cardiovascular Sciences, Microbiology, Immunology and Inflammation, and Biomedical Education and Data Science. His research focuses on epigenetic mechanisms in cardiovascular diseases (CVD), particularly how CVD risk factors influence histone modification and gene expression in vascular inflammation and atherosclerosis. Education: MD from JiangXi Medical University (1979), MS in Immunology from Chinese National Academy of Medical Sciences (1982), PhD in Biochemistry from University of Montreal (1994), and fellowship training in Immunology at Harvard Medical School (1999). Research interests span epigenetic pathology, metabolic disease pathways, thrombosis, and vascular immunology. Notable contributions include studies on metabolic crosstalk in metabolic syndrome, lysophospholipid signaling in atherosclerosis, and regulatory T cell epigenetics. His work integrates basic science with translational medicine, addressing mechanisms of vascular inflammation and therapeutic targets. Awards include Fellow of the American Heart Association (FAHA). Active in multiple research centers including the Sol Sherry Thrombosis Research Center and Center for Metabolic Disease Research. His publications (over 100) emphasize interdisciplinary approaches to cardiovascular and metabolic disorders.

Sue Aitkenمشاهده پروفایل

استاد

• Enzymology
• Sulfur Amino Acid Metabolism
• Phytoremediation
• +۴ مورد دیگر

Professor Sue Aitken is a faculty member in the Department of Biology at Carleton University, affiliated with the Faculty of Science. She holds a B.Sc. from McGill University, M.Sc. and Ph.D. from Concordia University, and completed a postdoctoral fellowship at Berkeley. Her research focuses on enzymology and sulfur amino acid metabolism, employing advanced techniques like PCR, site-directed mutagenesis, and biophysical spectroscopy. Key areas include methionine biosynthesis in plants, phytoremediation of heavy metals using hyperaccumulators, homocysteine metabolism's role in cardiovascular disease, and PLP-dependent enzyme engineering for biotech applications. Her work has implications for agriculture, environmental science, and medical therapeutics. Education: B.Sc. (McGill), M.Sc. (Concordia), Ph.D. (Concordia), Postdoctoral Studies (Berkeley). Research interests span plant protein enhancement, environmental detoxification via phytoremediation, and medical enzymology related to homocysteinuria. Techniques utilized include stopped-flow spectroscopy, isothermal titration calorimetry, and analytical ultracentrifugation. Her articles highlight enzyme mechanism elucidation and metabolic pathway analysis. Lab facilities are located in 323 Nesbitt Building, with an office in 5434 Herzberg Laboratories. Current projects aim to engineer enzymes for biotech applications and improve crop nutritional profiles through metabolic pathway understanding.

Mohammad Azam Mansoorمشاهده پروفایل

استاد

• Redox Biology
• Folate Metabolism
• Homocysteine Regulation
• +۶ مورد دیگر

Mohammad Azam Mansoor is a Professor at the Department of Natural Sciences, University of Agder (UiA). He holds a Ph.D. (dr. philos) from the Institute for Clinical Biology, Division of Pharmacology and Toxicology, University of Bergen (1994). His teaching spans Biochemistry, Medical Biochemistry, and Organic Chemistry, with a focus on research in redox biology, folate metabolism, and the interplay between nutrition and clinical biomarkers. Dr. Mansoor has contributed extensively to understanding how genetic polymorphisms, dietary interventions, and oxidative stress affect metabolic pathways, particularly in conditions like IgA nephropathy and cardiovascular health. Ph.D. (dr. philos), Institute for Clinical Biology, Division of Pharmacology and Toxicology, University of Bergen (1994) His research groups include Biomedicine and Health, Behavior, Diversity, and Social Inclusion. He has been a key contributor to studies on the systemic redox status in chronic diseases, the impact of B-vitamins, and analytical methodologies like HPLC for biomarker quantification. Dr. Mansoor has collaborated on interdisciplinary projects, including assessments of organic food safety and nutrient fortification models for the Norwegian Scientific Committee for Food Safety. His work often involves clinical trials and observational studies, linking biochemical markers to public health outcomes. Dr. Mansoor's recent publications highlight his expertise in redox biology, folate-homocysteine-glutathione dynamics, and pharmacogenomics. For instance, his 2025 study on antioxidant-enzyme gene SNPs' effects on plasma biomarkers after folic acid supplementation demonstrates his focus on personalized nutrition. Earlier works (2022, 2020) explore redox-inflammatory biomarkers in IgA nephropathy, while 2018-2015 studies address metabolic interactions in kidney disease and nutrient supplementation. His contributions to HPLC methodology and the biochemical impacts of antiepileptic drugs underscore his analytical and clinical research strengths.

• Biochemistry
• Metabolic Pathways
• Diabetes Research
• +۳ مورد دیگر

Dr. Enoka Wijekoon is a Teaching-Focussed Faculty Member in the Department of Molecular and Cellular Biology at the University of Guelph. He holds a BVSc from the University of Peradeniya (Sri Lanka), a PhD in Biochemistry from Memorial University of Newfoundland (Canada), and completed a CIHR-funded postdoctoral fellowship in Biomedical Sciences at Memorial University. His career spans veterinary clinical practice, academic research, and teaching. Currently, he focuses on enhancing student engagement in large biochemistry courses and exploring low-stakes assessments for knowledge retention. His research interests include metabolic and physiological studies of diabetes, homocysteine metabolism, and hypertension mechanisms. He has contributed to understanding creatine synthesis in neonatal mammals, insulin resistance effects on amino acid pathways, and vascular dysfunction in diabetes models. His work bridges basic biochemical research with translational health implications. Dr. Wijekoon coordinates undergraduate biochemistry courses (e.g., BIOC*2580, BIOC*4580) and supervises research projects (MCB*4500/4510). He has advised biochemistry and co-op programs for over a decade. His CIHR fellowship supported studies on angiotensin II-induced vascular dysfunction. Presentations at Experimental Biology and homocysteine conferences reflect his international research contributions.

• Nutritional Genetics
• Molecular Biology
• Genetics of Disease Processes
• +۵ مورد دیگر

Zoe Yates is a Lecturer in the School of Biomedical Sciences and Pharmacy at the University of Newcastle. She holds a PhD from the University of Leeds and has expertise in nutritional biochemistry, molecular biology, and genetics of disease processes, particularly focusing on folate bioavailability, B-vitamin metabolism, and their roles in conditions like heart disease, cancer, and neural tube defects. Her research also addresses the implications of mandatory folic acid fortification and fetal programming of adult diseases. Her career includes a Research Fellowship at the University of Newcastle (2007–2012) and postdoctoral roles at the University of Nottingham and University of Leeds. She has authored over 35 peer-reviewed publications in journals like Nature Reviews Genetics, Lancet, and Journal of the National Cancer Institute, and secured grants including the Ramaciotti Foundation Establishment Grant and University of Newcastle Strategic Pilot Grant. Teaching expertise includes research methods and ethics, while administrative roles involve laboratory management and health & safety. Collaborations focus on nutrigenomics, vitamin D-folate interactions, and epigenetic mechanisms. Awards include invitations to speak at the Asia Pacific Nutrigenomics Conference and Nutrition Society Australia events. Key research themes: Folate metabolism's role in health/disease, vitamin D-folate interactions, genetic polymorphisms' impacts, and mandatory fortification's dual effects. Active in professional bodies like the Nutrition Society of Australia and University of Newcastle's Institutional Biosafety Committee.

Ahmed Ibrahimمشاهده پروفایل

استادیار

• Ocular Angiogenesis
• Retinopathy of Prematurity (ROP)
• Proliferative Diabetic Retinopathy (PDR)
• +۴ مورد دیگر

Ahmed Ibrahim, Ph.D., is an Assistant Professor jointly appointed in the Departments of Ophthalmology, Visual and Anatomical Sciences, and Pharmacology at Wayne State University, where he also teaches graduate-level toxicology courses. Education Bachelor of Pharmacy (BSc. Pharm, Hons.), 2002 M.Sc. in Pharmaceutical Sciences, 2006 Ph.D. in Pharmaceutical Sciences, 2011 Research Focus Dr. Ibrahim’s laboratory investigates the molecular and cellular underpinnings of angiogenesis-driven ocular diseases . His work centers on pathological ocular angiogenesis , the root cause of blinding disorders such as retinopathy of prematurity (ROP) , proliferative diabetic retinopathy (PDR) , and exudative age-related macular degeneration (wet AMD) . A central theme is endothelial metabolic reprogramming , aiming to discover FDA-approved drugs that can be repurposed to modulate energy metabolism in angiogenic endothelial cells and overcome resistance to anti-VEGF therapy. Recent Publication Themes Across the last decade, Dr. Ibrahim’s publications reveal a consistent trajectory from mechanistic studies of lipoxygenase pathways and oxidative stress to translational models of diabetic retinopathy , traumatic optic neuropathy , and AMD . His work integrates in vitro retinal endothelial cell assays, in vivo mouse models of disease, and pharmacological interventions, underscoring a commitment to identifying non-VEGF therapeutic targets. Teaching & Courses BIO7011 – Principles of Toxicology (Fall 2023) PHC7410 – Principles of Toxicology (Fall 2023) Contact Email: gt3759@wayne.edu

Clark A Lindgrenمشاهده پروفایل

استاد

• Neuroscience
• Synaptic transmission
• Neuromuscular junction
• +۴ مورد دیگر

Clark A. Lindgren is a Professor and holds the Patricia A. Johnson Professorship of Neuroscience at Grinnell College. He is affiliated with the Department of Biology, Department of Biological Chemistry, and the Neuroscience program. His research focuses on the chemical synapse, particularly the neuromuscular junction, where neurons communicate with neighboring cells. Dr. Lindgren earned his B.S. in Physics from Wheaton College, followed by M.S. and Ph.D. degrees in Physiology from the University of Wisconsin-Madison. He completed postdoctoral training in Neurobiology at Duke University. Dr. Lindgren's research primarily investigates synaptic transmission and plasticity at the neuromuscular junction. His laboratory studies how presynaptic cells regulate neurotransmitter release and how synapses maintain stability through processes like presynaptic homeostatic potentiation (PHP). A key focus of his recent work has been exploring the role of hydrogen ions (protons) as potential mediators in PHP, challenging long-standing mysteries in neuroscience that have persisted for over four decades. Analysis of Dr. Lindgren's recent publications reveals a consistent focus on synaptic mechanisms at the neuromuscular junction across multiple model organisms (mouse, lizard, frog, Drosophila). His work spans multiple disciplines including neurophysiology, neuropharmacology, and molecular neuroscience, with particular emphasis on the roles of nitric oxide, endocannabinoids, and prostaglandins in modulating synaptic transmission. His research demonstrates an evolution from studying basic neurotransmitter release mechanisms to investigating complex synaptic homeostasis processes involving multiple cell types (the "tripartite synapse" including nerve, muscle, and glial cells). Dr. Lindgren holds the distinguished Patricia A. Johnson Professorship of Neuroscience, reflecting his significant contributions to the field. Over 90 undergraduate students have worked in Dr. Lindgren's laboratory since 1990, contributing to numerous publications where student researchers are denoted with asterisks. His mentoring has provided extensive research opportunities for undergraduates, with students contributing to all aspects of experimental design, execution, and publication. His laboratory has received support for undergraduate research training, though specific grant details are not provided in the available text. Dr. Lindgren's laboratory employs a range of techniques including electrophysiology, confocal microscopy, immunofluorescence, computational modeling, and molecular approaches to study synaptic function. Current projects focus on measuring pH in the synaptic cleft, exploring the morphology of synapses at the neuromuscular junction, computationally simulating pH responses, and investigating PHP mechanisms in the presence of postsynaptic action potentials.

• Plant Molecular Biology
• Photosynthesis
• Light Perception in Plants
• +۴ مورد دیگر

Andrea Trotta is a Senior Researcher at the Institute of Biosciences and BioResources (IBBR) of the National Research Council of Italy (CNR), based in Sesto Fiorentino, Florence. He has held this position since January 2023, following previous roles as a Researcher at the same institution from November 2019 to December 2022. Dr. Trotta maintains significant international collaborations, particularly with the University of Turku in Finland, where he has served as a Visiting Researcher since April 2021. Dr. Trotta earned his PhD in Environmental Sciences from the Department of Environmental and Life Sciences (DiSAV) at the University of Eastern Piedmont in Alessandria, Italy, between November 2006 and February 2010. His doctoral research laid the foundation for his subsequent work in plant molecular biology and photosynthesis. His research focuses on the molecular mechanisms underlying light perception and energy conversion in biomolecules across both model and non-model land plant species. Specifically, he investigates the regulation of expression and post-translational modification of the proteome in photosynthetic membranes and whole plant cells. His work spans plant molecular biology, photosynthesis, and chloroplast function, with particular emphasis on protein phosphorylation dynamics and thylakoid membrane organization. Analysis of Dr. Trotta's recent publications reveals a strong research trajectory focused on thylakoid membrane structure and function across diverse plant species. His work examines protein phosphorylation dynamics in response to environmental stimuli, photosynthetic adaptation mechanisms in conifers during winter conditions, and the evolutionary aspects of photosynthetic regulation from mosses to vascular plants. His research bridges fundamental molecular mechanisms with ecological adaptations. Dr. Trotta has been involved in multiple research projects funded by prestigious organizations including the Academy of Finland and the Jane and Aatos Erkko Foundation. His collaborations with Prof. Eva-Mari Aro at the University of Turku have been particularly significant, focusing on photosynthetic mechanisms and molecular biology of primary producers. He maintains active research collaborations across international institutions, particularly with the University of Turku in Finland, where he has served as a Visiting Researcher since April 2021 and previously held Senior Research Fellow and Senior Researcher positions. His work has been supported by multiple Academy of Finland projects investigating photosynthetic mechanisms, regulation, and signaling.

Guoying Wangمشاهده پروفایل

پژوهشگر

• Obesity
• Diabetes
• Epidemiology
• +۴ مورد دیگر

Guoying Wang , MD, PhD, is an Associate Scientist at the Bloomberg School of Public Health , Johns Hopkins University , with primary affiliations in the Department of Population, Family and Reproductive Health and the Center on the Early Life Origins of Disease . Her research bridges early life exposures and adult chronic diseases, focusing on obesity, diabetes, and metabolic disorders. Education: MD from Beijing Medical University (1989), PhD from Peking University Research Interests include: Obesity and Diabetes : Investigating maternal factors influencing pediatric and adult metabolic risks Environmental Health : Impact of heavy metals, PFAS, and mercury on child development Epidemiology : Longitudinal studies via the Boston Birth Cohort Scientific Trends from her publications highlight: Prenatal exposure to environmental toxins (PFAS, mercury) linked to obesity and neurodevelopmental disorders Role of maternal nutrition (folate, manganese) in mitigating metabolic risks Multi-omics approaches to study immune development and epigenetic mechanisms

Mark Styczynskiمشاهده پروفایل

استاد

• Metabolic Engineering
• Systems Biology
• Synthetic Biology
• +۵ مورد دیگر

Mark Styczynski is a Professor at the Georgia Institute of Technology , holding the William R. McLain Endowed Term Professorship in the School of Chemical and Biomolecular Engineering within the College of Engineering . His research integrates systems biology , synthetic biology , and metabolomics to understand and engineer metabolic systems for applications in biotechnology and medicine. Education: B.S. 2002, University of Notre Dame Ph.D. 2007, Massachusetts Institute of Technology Research Interests: Mark Styczynski's lab focuses on the experimental and computational study of metabolic dynamics and regulation , with applications in metabolic engineering , synthetic biology , and biosensor development . His group uses metabolomics to measure biochemical intermediates in real time, enabling the modeling and control of cellular behavior. This work spans cancer cells , stem cells , yeast , and E. coli , aiming to manipulate metabolism for therapeutic and industrial purposes. The lab also develops synthetic biology tools , including bacterial biosensors that produce visible pigments for diagnostics. Scientific Awards: William R. McLain Endowed Term Professorship Advising & Team: Mark Styczynski actively mentors a diverse group of graduate students and researchers. Recent achievements by his advisees include: Karly — NSF Graduate Research Fellowship (2025), 1st place in Bioengineering "Rapid Fire" competition Ziqi — Passed Bioengineering Qualifying Exam (2025) Jiho — 3rd place in Bioengineering "Rapid Fire" competition, Ph.D. candidate (2025) Soor — Ph.D. candidate (2025) Harini — Finalist in 3MT presentation Labs & Teams: He leads the Styczynski Research Group , which operates within the School of Chemical and Biomolecular Engineering at Georgia Tech. The group integrates wet-lab experimentation with computational modeling, focusing on high-dimensional, time-course metabolomics data to drive discoveries in metabolic control and biosensor development.

• Neuroscience
• Biomedical Engineering
• Endocrinology
• +۳ مورد دیگر

Sandesh Kamdi is a Postdoctoral Fellow in the Department of Diagnostic Radiology and Nuclear Medicine, conducting interdisciplinary research at the intersection of neuroscience, biomedical engineering, and reproductive medicine. Education: PhD, MPharm, BM. His primary research domains include: Neuroscience: Developing non-invasive neuromodulation techniques using low-intensity focused ultrasound for epilepsy treatment Diabetes Research: Investigating natural compounds like phloridzin for cognitive and metabolic complications Reproductive Medicine: Optimizing therapies for polycystic ovary syndrome and pregnancy outcomes Publication analysis reveals a translational research trajectory, with recent work (2021-2024) emphasizing neuromodulation technologies for neurological disorders and phytochemical interventions for metabolic diseases, bridging animal model studies with clinical applications. His scholarly contributions demonstrate expertise in designing controlled animal studies, retrospective clinical analyses, and bioequivalence testing, with consistent focus on mechanistic pathways involving oxidative stress, inflammatory responses, and neural network modulation.